Comparative analysis of plasma folate, homocysteine and erythrocyte folate levels in pregnant women after folic acid administration during different pregnancies
Comparison of Folate and Homocysteine in Pregnancies
Abstract
Background: To examine and evaluate the alterations in plasma folate, homocysteine (HCY), and erythrocyte folate (FOA) concentrations among expectant mothers following folic acid supplementation in distinct pregnancies.
Methods: A retrospective analysis was conducted on clinical data from 416 pregnant women admitted to our hospital between October 2020 and October 2023. These women were selected as the subjects of observation and divided into two groups based on their folic acid intake duration: an observation group (n=210) who consumed folic acid before and during early pregnancy, and continued taking it throughout mid and late pregnancy (≥ 20 days per month), and a control group (n=206) who took folic acid before and during early pregnancy but did not continue taking it in mid and late pregnancy (≥ 20 days per month). The prenatal levels of folate, HCY, and FOA were compared among the different groups of pregnant women. Pearson correlation analysis was used to explore the relationship between changes in folate, HCY, and FOA levels in pregnant women. Moreover, the fasting blood glucose (FBG) and 2-hour postprandial blood glucose (P2BG) levels were compared between the two groups of pregnant women. The incidence of gestational diabetes (GDM), gestational hypertension (HIP), and gestational anemia were also compared. Additionally, comparisons were made regarding the changes in delivery mode, newborn height, weight, head circumference, and chest circumference between the two groups of pregnant women.
Results: The control group exhibited significantly lower levels of plasma folate and FOA compared to the observation group, while the levels of HCY were significantly higher in the control group than in the observation group, with statistically significant differences (P<0.05). Results from Pearson correlation analysis indicated a significant positive correlation between plasma folate and FOA (r=0.116, P<0.05), a significant negative correlation between plasma folate and HCY (r=-0.411, P<0.05), and a significant negative correlation between plasma FOA and HCY (r=-0.286, P<0.05). The levels of FBG and P2BG during pregnancy were found to be significantly lower in the observation group compared to the control group, with statistically significant differences (P<0.05). Furthermore, the incidence of gestational anemia and HIP was significantly lower in the observation group than in the control group, with statistically significant differences (P<0.05). The occurrence of cesarean section was significantly lower in the observation group compared to the control group. The newborns in both groups exhibited normal height, weight, head circumference, and chest circumference. Notably, the newborns in the observation group had significantly higher values for height, weight, head circumference, and chest circumference compared to those in the control group, with statistically significant differences (P<0.05).
Conclusion: By consuming folic acid before and during early pregnancy, and consistently throughout mid and late pregnancy, it is possible to increase the levels of folic acid and FOA in pregnant women's bodies. This, in turn, facilitates rapid foetal development, enhances the nutritional status of newborns, and decreases the likelihood of cesarean section. Additionally, early supplementation of folic acid can effectively reduce the occurrence of pregnancy-related complications, thereby improving the prognosis for both mothers and infants.
References
2. Caffrey A, McNulty H, Rollins M, Prasad G, Gaur P, Talcott JB, et al. Effects of maternal folic acid supplementation during the second and third trimesters of pregnancy on neurocognitive development in the child: an 11-year follow-up from a randomised controlled trial. Bmc Med 2021; 19(1): 73.
3. Sayar EH, Orhaner BB, Sayar E, NesrinTuran F, Kucuk M. The frequency of vitamin B12, iron, and folic acid deficiency in the neonatal period and infancy, and the relationship with maternal levels. Turk Pediatr Arsivi 2020; 55(2): 139-48.
4. Adhikari KM, Singh S, Kannan V, Mathai S. A study on periconceptional folic acid supplement intake and serum folic acid levels in pregnant mothers. Med J Armed Forces India 2022; 78(Suppl 1): S246-50.
5. Jin X, Cheng Z, Yu X, Tao Q, Huang R, Wang S. Continuous supplementation of folic acid in pregnancy and the risk of perinatal depression-A meta-analysis. J Affect Disorders 2022; 302: 258-72.
6. Ferrazzi E, Tiso G, Di Martino D. Folic acid versus 5- methyl tetrahydrofolate supplementation in pregnancy. Eur J Obstet Gyn R B 2020; 253: 312-9.
7. van der Windt M, Schoenmakers S, van Rijn B, Galjaard S, Steegers-Theunissen R, van Rossem L. Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy. Nutrients 2021; 13(2): 331.
8. Wegner C, Kancherla V, Lux A, Kohn A, Bretschneider D, Freese K, et al. Periconceptional folic acid supplement use among women of reproductive age and its determinants in central rural Germany: Results from a cross sectional study. Birth Defects Res 2020; 112(14): 1057-66.
9. Silveira JS, Ramires JO, Schmitz F, Ferreira FS, Rodrigues FC, Silva RC, et al. Folic acid supplementation during pregnancy alters behavior in male rat offspring: nitrative stress and neuroinflammatory implications. Mol Neurobiol 2022; 59(4): 2150-70.
10. Cawley S, O'Malley EG, Kennedy R, Reynolds C, Molloy AM, Turner MJ. The relationship between maternal plasma homocysteine in early pregnancy and birth weight. J Matern-Fetal Neo M 2020; 33(18): 3045-9.
11. Lutz BH, Santos I, Domingues MR, Murray J, Silveira M, Miranda V, et al. Folic acid supplementation during pregnancy and postpartum depressive symptoms. Rev Saude Publ 2023; 57: 76.
12. Yan Y, Xie C, Di S, Wang Z, Wu M, Li Y, et al. Supplemental folic acid and/or multivitamins in pregnancy is associated with a decreased risk of childhood and adolescent nasopharyngeal carcinoma. J Dev Orig Hlth Dis 2022; 13(5): 550-5.
13. Liu HY, Liu SM, Zhang YZ. Maternal Folic Acid Supplementation Mediates Offspring Health via DNA Methylation. Reprod Sci 2020; 27(4): 963-76.
14. Chen H, Zhang Y, Wang D, Chen X, Li M, Huang X, et al. Periconception Red Blood Cell Folate and Offspring Congenital Heart Disease : Nested Case-Control and Mendelian Randomization Studies. Ann Intern Med 2022; 175(9): 1212-20.
15. Hunt SE, Netting MJ, Sullivan TR, Best KP, Houghton LA, Makrides M, et al. Red Blood Cell Folate Likely Overestimated in Australian National Survey: Implications for Neural Tube Defect Risk. Nutrients 2020; 12(5): 1283.
16. Saravanan P, Sukumar N, Adaikalakoteswari A, Goljan I, Venkataraman H, Gopinath A, et al. Association of maternal vitamin B(12) and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study). Diabetologia 2021; 64(10): 2170-82.
17. Menezo Y, Elder K, Clement A, Clement P. Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles. Biomolecules 2022; 12(2): 197.
18. Owen MD, Baker BC, Scott EM, Forbes K. Interaction between Metformin, Folate and Vitamin B(12) and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies. Int J Mol Sci 2021; 22(11): 5759.
Copyright (c) 2024 Xinglin Jin, Mei Meng, Xi Wang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.